| Literature DB >> 34098069 |
Jie Tang1, Mingrong Bei2, Jia Zhu3, Guangtao Xu3, Deqing Chen3, Xin Jin3, Jianzhong Huang4, Jingjian Dong5, Lili Shi5, Long Xu6, Bo Hu7.
Abstract
Cadmium (Cd) exposure can exert an impact on carcinogenicity of breast cancer, however, the mechanism is not fully understood in triple-negative breast cancer (TNBC). We performed a TNBC MDA-MB-231 cell model and assessed the toxic effect of Cd exposure (0, 10, 20, 50, 60, 80 μM). Cd reduced cell viability in a time- and dose-dependent manner, followed by cell cycle arrest in S phase with alterations of cyclin 1A1, cyclin 1D1 and CDK2. Lactate dehydrogenase (LDH) release, apoptosis and pyroptosis were increased, which were relieved by z-VAD. Elevated ROS and NLRP3, caspase-1, IL-1β and IL-18 were detected, which was attenuated by N-acetylcysteine. Increased bax and decreased caspase-8, caspase-9 and caspase-3 were found. gasdermin E (GSDME) was activated with cleavage of GSDME-NT, which was retarded by z-VAD. Additionally, p38 MAPK signaling pathway was activated. Our data demonstrate GSDME-activated pyroptosis in Cd toxicity, implying a potential impact on TNBC.Entities:
Keywords: Cadmium; GSDME; MDA-MB-231cells; NLRP3 inflammasome; Pyroptosis; ROS
Year: 2021 PMID: 34098069 DOI: 10.1016/j.etap.2021.103686
Source DB: PubMed Journal: Environ Toxicol Pharmacol ISSN: 1382-6689 Impact factor: 4.860